United States · Bill · HR
H.R. 5763 (114th)
Prostate Cancer Misdiagnosis Elimination Act of 2016
Introduced
13 July 2016
Last action
—
Status
Referred to the Subcommittee on Health.
Sponsors
—
Subjects
Discovery layer
Source updated
12 August 2025
Summary
Prostate Cancer Misdiagnosis Elimination Act of 2016 This bill specifies that, unless the physician ordering a DNA Specimen Provenance Assay (DSPA) test recommends otherwise, a DSPA test furnished with respect to a positive prostate cancer biopsy shall be deemed to be medically necessary for purposes of Medicare.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 13 July 2016
Introduced in House (PDF)
Introduced in House · EN · 13 July 2016
Introduced in House
summary · EN · 13 July 2016
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/114th-congress/house-bill/5763
- Open data entity: https://api.congress.gov/v3/bill/114/hr/5763